Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers.
Sixty asymptomatic cigarette smokers were randomly allocated into three treatment groups. Smokers in Group 1 received 900 international units of Vitamin E (VE) daily for 6 wk, whereas 40 mg of beta-carotene (BC) daily was administered to those in Group 2 for the same period. Subjects in Group 3 were treated with a matched placebo. Plasma levels of VE and BC as well as circulating leukocyte counts, sister chromatid exchanges (SCEs), and the luminol-enhanced chemiluminescence (LECL) responses of blood phagocytes activated with phorbol myristate acetate (PMA) and FMLP with cytochalasin B (FMLP/CB) were measured prior to the administration of the antioxidant/placebo after 4 and 6 wk of supplementation and 12 wk after cessation of treatment. SCEs and leukocyte counts remained unchanged throughout the trial in all three treatment groups. Administration of VE for 4 wk was accompanied by decreased FMLP/CB-activated (p less than 0.005) and PMA-activated (p less than 0.005) LECL responses. However, with PMA as stimulant, the inhibition of LECL was transient, with partial recovery observed after 6 wk despite continued administration of VE. Administration of BC was associated with progressive inhibition of both FMLP/CB-activated (p less than 0.05 and p less than 0.01 after 4 and 6 wk, respectively) and PMA-activated (p less than 0.025 after 6 wk) LECL. No alterations in LECL responses were observed in Group 3 (placebo). VE appeared to inhibit the generation of oxidants by activated phagocytes, whereas BC scavenged oxidants generated by the myeloperoxidase/H2O2/halide system.
Richards
G A
GA
Department of Medicine, Coronation Hospital, Transvaal, Republic of South Africa.
Theron
A J
AJ
Van Rensburg
C E
CE
Van Rensburg
A J
AJ
Van der Merwe
C A
CA
Kuyl
J M
JM
Anderson
R
R
D000166:Acridines / Q000494:pharmacology; D000284:Administration, Oral; D000328:Adult; D002338:Carotenoids / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects; D007962:Leukocytes / Q000187:drug effects* / Q000378:metabolism / Q000648:ultrastructure; D008163:Luminescent Measurements; D008165:Luminol / Q000494:pharmacology; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012854:Sister Chromatid Exchange / Q000187:drug effects*; D012907:Smoking / Q000097:blood* / Q000235:genetics; D013481:Superoxides / Q000378:metabolism; D014810:Vitamin E / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D019207:beta Carotene
D000166:Acridines; D019207:beta Carotene; D013481:Superoxides; D014810:Vitamin E; C033472:10,10'-dimethyl-9,9'-biacridinium; D002338:Carotenoids; D008165:Luminol